These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2824753)

  • 1. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
    Negus SS; Burke TF; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1989 Nov; 251(2):455-60. PubMed ID: 2553919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
    Dykstra LA; Massie CA
    J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
    Walker EA; Butelman ER; DeCosta BR; Woods JH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):280-6. PubMed ID: 7901396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
    France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.